ATE250411T1 - Ein nsaid und misoprostol enthaltende arzneitablette - Google Patents

Ein nsaid und misoprostol enthaltende arzneitablette

Info

Publication number
ATE250411T1
ATE250411T1 AT00305965T AT00305965T ATE250411T1 AT E250411 T1 ATE250411 T1 AT E250411T1 AT 00305965 T AT00305965 T AT 00305965T AT 00305965 T AT00305965 T AT 00305965T AT E250411 T1 ATE250411 T1 AT E250411T1
Authority
AT
Austria
Prior art keywords
misoprostol
tablet containing
medicinal tablet
containing nsaid
nsaid
Prior art date
Application number
AT00305965T
Other languages
English (en)
Inventor
Bernard Charles Sherman
Original Assignee
Bernard Charles Sherman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bernard Charles Sherman filed Critical Bernard Charles Sherman
Application granted granted Critical
Publication of ATE250411T1 publication Critical patent/ATE250411T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00305965T 1999-07-14 2000-07-13 Ein nsaid und misoprostol enthaltende arzneitablette ATE250411T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002277407A CA2277407A1 (en) 1999-07-14 1999-07-14 Pharmaceutical tablet comprising an nsaid and misoprostol

Publications (1)

Publication Number Publication Date
ATE250411T1 true ATE250411T1 (de) 2003-10-15

Family

ID=4163733

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00305965T ATE250411T1 (de) 1999-07-14 2000-07-13 Ein nsaid und misoprostol enthaltende arzneitablette

Country Status (9)

Country Link
US (1) US6656503B1 (de)
EP (1) EP1068867B1 (de)
JP (1) JP2001039876A (de)
AT (1) ATE250411T1 (de)
AU (1) AU776430B2 (de)
CA (1) CA2277407A1 (de)
DE (1) DE60005438T2 (de)
ES (1) ES2207466T3 (de)
ZA (1) ZA200003511B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319519B2 (en) 1998-07-07 2001-11-20 Norton Healthcare Ltd. Anti-inflammatory pharmaceutical formulations
US6387410B1 (en) 1998-09-10 2002-05-14 Norton Healthcare Ltd Anti-inflammatory pharmaceutical formulations
EP1216030A1 (de) * 1999-10-01 2002-06-26 Norton Healthcare Limited Entzündungshemmende pharmazeutische formulierungen
WO2002066030A1 (en) * 2001-02-22 2002-08-29 Ono Pharmaceutical Co., Ltd. Medicinal compositions comprising diclofenac and ornoprostil
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
EP1411900B2 (de) * 2001-06-01 2013-12-04 Pozen, Inc. Pharmazeutische zusammensetzungen für die koordinierte abgabe von nsaid
AU2003262264A1 (en) * 2002-08-22 2004-03-11 Ono Pharmaceutical Co., Ltd. Agent for reducing side effects of diclofenac
EP1462098B1 (de) * 2003-03-03 2007-07-04 SPRL Franpharma Stabilisierte pharmazeutische Zusammensetzung enthaltend einen NSAID und einen Prostaglandin
MXPA06003352A (es) * 2003-09-24 2006-06-08 Novartis Consumer Health Sa Tabletas revestidas.
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
US9265732B2 (en) 2006-03-06 2016-02-23 Pozen Inc. Dosage forms for administering combinations of drugs
US20090022786A1 (en) * 2007-07-16 2009-01-22 Yung Shin Pharm. Ind. Co., Ltd. Oral pharmaceutical dosage form and manufacturing method thereof
EA201100313A1 (ru) 2008-09-09 2011-10-31 Астразенека Аб Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом
EP2210595A1 (de) 2009-01-14 2010-07-28 LEK Pharmaceuticals d.d. Aktive Beschichtung von pharmazeutischen Dosierungsformen
CA2764963C (en) 2009-06-25 2016-11-01 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
BR112014016085A8 (pt) 2011-12-28 2017-07-04 Pozen Inc composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico
AU2015377223A1 (en) * 2015-01-12 2017-08-31 Nano Pharmaceutical Laboratories Llc Layered sustained-release microbeads and methods of making the same
CN111700872A (zh) * 2020-07-20 2020-09-25 华益药业科技(安徽)有限公司 一种双氯芬酸肠溶片及其加工工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4301146A (en) 1980-07-29 1981-11-17 G. D. Searle & Co. Stabilization of 16-oxygenated prostanoic acid derivatives
AU7876491A (en) 1990-05-03 1991-11-27 G.D. Searle & Co. Pharmaceutical composition
WO1991016886A1 (en) * 1990-05-03 1991-11-14 G.D. Searle & Co. Pharmaceutical composition containing ibuprofen and a prostaglandin
DE4220123A1 (de) * 1991-09-18 1993-04-01 Schering Ag Pharmazeutische praeparate
ES2173096T3 (es) * 1992-08-05 2002-10-16 Faulding F H & Co Ltd Composicion farmaceutica peletizada.

Also Published As

Publication number Publication date
ES2207466T3 (es) 2004-06-01
DE60005438D1 (de) 2003-10-30
EP1068867A3 (de) 2001-04-25
EP1068867B1 (de) 2003-09-24
DE60005438T2 (de) 2004-07-08
JP2001039876A (ja) 2001-02-13
AU776430B2 (en) 2004-09-09
AU4719200A (en) 2001-01-18
CA2277407A1 (en) 2001-01-14
EP1068867A2 (de) 2001-01-17
ZA200003511B (en) 2001-02-05
US6656503B1 (en) 2003-12-02

Similar Documents

Publication Publication Date Title
DE60005438D1 (de) Ein NSAID und Misoprostol enthaltende Arzneitablette
NO982613D0 (no) Legemiddelavleveringsanordning
NO963990D0 (no) To-komponentanordning for tilförsel av medikamenter
ATE203161T1 (de) Polymer umhüllte tablette enthaltend amoxicillin und clavulanat
DK0998304T3 (da) Farmaceutisk præparat. der omfatter et basisk lægemiddel, en cyclodextrin, en polymer og en syre
ATA903696A (de) Elektrotransport-medikamentenverabreichung
NL1001410C2 (nl) Medische inrichting voor langdurig verblijf in een lichaam.
AU7451600A (en) Optical device with multilayer thin film and aligner with the device
EP1078628A3 (de) Aus vielen Einzeleinheiten zusammengesetzte tablettierte Dosisform
FI941197A7 (fi) Lääkkeenannostuslaite
ATE548029T1 (de) Wirkstoffabgabevorrichtung mit verzögerter freisetzung
DE69941728D1 (de) Medizinischer artikel mit flüssigkeitskontrollierendem film
DE69832816D1 (de) Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung
DE69427472D1 (de) Arzneimittel mit kontrollierter Wirkstoffabgabe
DK1041975T3 (da) Hastighedskontrollerende membraner til anordninger til kontrolleret indførsel af medikament
DE3884237D1 (de) Beschichtete Kunststoffolie und daraus hergestelltes Kunststofflaminat.
NO20003056D0 (no) Anordning for levering av et væskeinneholdende medikament
FR2683146B1 (fr) Compositions pharmaceutiques a liberation reglee de la substance medicamenteuse.
MA26549A1 (fr) Medicaments
ATE252379T1 (de) Orale pharmazeutische dosierungsform beruhend auf stossweiser freisetzung
FR2653338B1 (fr) Formulation pour des pansements a liberation prolongee de medicament et son utilisation.
BR9713237B1 (pt) comprimido de liberaÇço controlada de cloridrato de alfuzosina e composiÇço farmacÊutica compreendendo o mesmo.
ATE208614T1 (de) Stabile, gelatinüberzogene aspirintabletten
NO20020531D0 (no) Beta-carbolin medikament produkter
EP0691841A4 (de) Medikamente abgebende stents

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties